HIGH REMISSION AND LOW RECURRENCE RATES OF HIDRADENITIS SUPPURATIVA LESIONS TREATED BY REGIONAL COMPLETE EXCISION AND SECONDARY INTENTION WOUND HEALING AFTER 36 MONTHS OF FOLLOW-UP

Authors

  • E. Hristakieva Department of Dermatology and Venereology, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria”, Clinic of Dermatology and Venereology, UMHAT “Prof. Dr Stoyan Kirkovich“, Stara Zagora, Bulgaria Author
  • P. K. Kohl Department of Dermatology and Venereology, Vivantes Network for Health, Berlin, Germany, Practice Hautärzte am Kurfürstendamm, Berlin, Germany Author
  • T. Gancheva Department of Dermatology and Venereology, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria”, Clinic of Dermatology and Venereology, UMHAT “Prof. Dr Stoyan Kirkovich“, Author
  • K. Manuelyan Department of Dermatology and Venereology, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria”, Clinic of Dermatology and Venereology, UMHAT “Prof. Dr Stoyan Kirkovich“, Stara Zagora, Bulgaria Author
  • R. Deliyska Department of Dermatology and Venereology, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria”, Clinic of Dermatology and Venereology, UMHAT “Prof. Dr Stoyan Kirkovich“, Stara Zagora, Bulgaria Author
  • D. Gancheva Clinic of Dermatology and Venereology, UMHAT “Prof. Dr Stoyan Kirkovich“, Stara Zagora, Bulgaria Author
  • R. Lavcheva Department of Dermatology and Venereology, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria”р Clinic of Dermatology and Venereology, UMHAT “Prof. Dr Stoyan Kirkovich“, Stara Zagora, Bulgaria Author

DOI:

https://doi.org/10.15547/tjs.2024.03.007

Keywords:

acne inversa, maladie de Velpeau-Verneuil, disease control

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease which mostly affects intertriginous skin areas. For its advanced stage, regional complete surgical excision (CSE), followed by healing by secondary intention is a useful treatment modality.

PURPOSE: We performed a pilot case series study to calculate remission and defined recurrence rates of HS lesions after regional CSE.

METHODS: 44 regional CSE were performed in 22 patients with Hurley stage II/III disease. The mean resulting wound size was 96 cm². After completed reepithelization by secondary intention, patients were under regular face-to-face follow-up for 36 months at the Clinic of Dermatology and Venereology in Stara Zagora. New HS lesions within 1 cm around the resulting scar were rated as regional recurrence.

RESULTS: 42/44 (95.5%) excision sites showed complete scarring without hypertrophic scar, keloid formation, functional impairment or lymphedema. Regional recurrence was detected in 2/44 (4.5%) excision sites. New HS lesions distant from the regional excision site developed in 1/22 (4.5%) patients.

CONCLUSIONS: Our results underscore the high remission and low defined recurrence rates of treatment of advanced HS lesions by regional CSE and secondary intention wound healing and further support the significance of this treatment modality for long-term disease control.

References

Hristakieva, E., Manuelyan, K., Gancheva, T., Lavcheva, R., Deliyska, R., Hidradenitis suppurativa from the typical patient to the new clinical phenotypes. Clin Dermatol, 41:584-591, 2023.

Chen,W., Plewig G. Should hidradenitis suppurativa/acne inversa best be renamed as "dissecting terminal hair folliculitis"?. Exp Dermatol, 26(6):544-547. 2017.

Wyant, W. A., Manjaly, P., Orlowski, G. M., Hidradenitis suppurativa: a new, principle-centered paradigm for managing a dynamic disease. Int J Dermatol. 2024 Mar 1. doi: 10.1111/ijd.17105. Epub ahead of print. PMID: 38425315.

Salame, N., Sow YN, Siira, MR,, et al. Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2024;160(2):179-186. doi:10.1001/jamadermatol.2023.5425.

Molinelli, E., De Simoni, E., Candelora, M., et al. Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues. Antibiotics (Basel). 12(6):978, 2023.

Aarts, P., van Huijstee, J. C., van der Ze, H. H., van Straalen K. R., Prens, E. P. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa. J Eur Acad Dermatol Venereol. Published online December 19, 2023. doi:10.1111/jdv.19725.

Orenstein, L. A. V., Nguyen, T. V., Damiani, G., Sayed, C., Jemec, G. B.E, Hamzavi, I. Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice. Dermatology, 236:393-412, 2020.

Zouboulis, C. C., Bechara, F. G., Dickinson-Blok, J.L,, Gulliver, W., Horváth, B., Hughes, R., Kimball, A.B., Kirby, B., Martorell, A., Podda, M., Prens, E. P., Ring, H.C., Tzellos, T., van der Zee, H.H., van Straalen, K.R., Vossen, A. R. J. V., Jemec, G. B. E. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol,33:19-31, 2019.

Alikhan, A., Sayed, C., Alavi, A., et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol, 81(1):91-101, 2019. doi:10.1016/j.jaad.2019.02.068

Gulliver, W., Zouboulis, C. C., Prens, E., Jemec, G.B., Tzellos, T. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord, 17(3):343-351, 2016.

Bui, H., Bechara, F.G., George, R., et al. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus. JAMA Dermatol, 159(4):441-447, 2023.

Shukla, R., Karagaiah, P., Patil, A., et al. Surgical Treatment in Hidradenitis Suppurativa. J Clin Med. 2022;11(9):2311 Published 2022 Apr 21. doi:10.3390/jcm11092311

Chawla, S., Toale, C., Morris, M., Tobin, A. M., Kavanagh, D. Surgical Management of Hidradenitis Suppurativa: A Narrative Review. J Clin Aesthet Dermatol, 15(1):35-41, 2022.

Wollina, U., Brzezinski, P., Koch, A., Philipp-Dormston, W. G. Immunomodulatory drugs alone and adjuvant to surgery for hidradenitis suppurativa/acne inversa-A narrative review. Dermatol Ther. 2020;33(6):e13877. doi:10.1111/dth.13877

Manfredini, M., Garbarino, F., Bigi, L., Pellacani, G., Magnoni, C. Hidradenitis Suppurativa: Surgical and Postsurgical Management. Skin Appendage Disord, 6(4):195-201, 2020.

Wollina, U., Langner, D., Heinig, B., Nowak, A. Comorbidities, treatment,and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report. Int J Dermatol, 56:109-115, 2017.

Gasslitter, I., Häfner, H. M., Kofler, K., Kofler, L. Postoperative Wundversorgung mit individuell angefertigten Wundauflagen bei Hidradenitis suppurativa: Wundversorgung nach radikaler Exzision mit sekundärem Wundverschluss [Postoperative wound care with custom-made wound dressings for hidradenitis suppurativa: Wound care after radical excision with secondary wound closure] [published correction appears in Dermatologie (Heidelb). 2024 Jan 8;:]. Dermatologie (Heidelb). 2022;74(12):994-996. doi:10.1007/s00105-023-05247-x

Gierek, M., Bergler-Czop, B., Łabuś, W., Ochała-Gierek, G., Niemiec, P. Reconstructive surgical treatment of hidradenitis suppurativa with a 6-month follow-up. Postepy Dermatol Alergol. 40(2):268-272, 2023.

Vaillant, C., Berkane, Y., Lupon,. E, et al. Outcomes and Reliability of Perforator Flaps in the Reconstruction of Hidradenitis Suppurativa Defects: A Systemic Review and Meta-Analysis. J Clin Med. 2022;11(19):5813, Published 2022 Sep 30. doi:10.3390/jcm11195813

Janek, K. C., Kenfield, M., Arkin, L. M., et al. Outcomes and cost of medical and surgical treatments of pilonidal disease: A single institution's 10-year review. Surg Open Sci, 9:41-45. 2022.

Ovadja, Z. N., Zugaj, M., Jacobs, W., van der Horst, C. M. A. M,., Lapid, O. Recurrence Rates Following Reconstruction Strategies After Wide Excision of Hidradenitis Suppurativa: A Systematic Review and Meta-analysis. Dermatol Surg. 2021;47(4):e106-e110. doi:10.1097/DSS.0000000000002815.

Riddle, A., Westerkam, L., Feltner, C., Sayed, C. Current Surgical Management of Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis. Dermatol Surg, 47(3):349-354, 2021.

Ovadja, Z. N., Jacobs, W., Zugaj, M., van der Horst, C. M. A. M., Lapid, O. Recurrence rates following excision of hidradenitis suppurativa: A systematic review and meta-analysis. Dermatol Surg 2020; 46:e1-e7. doi: 10.1097/DSS.0000000000002403.

Saylor, D. K., Brownstone, N.D., Naik, H. B. Office-Based Surgical Intervention for Hidradenitis Suppurativa (HS): A Focused Review for Dermatologists. Dermatol Ther (Heidelb), 10(4):529-549, 2020.

Bouazzi, D., Chafranska, L., Saunte, D. M. L., Jemec, G. B. E. Systematic review of complications and recurrences after surgical interventions in hidradenitis suppurativa. Dermatol Surg, 46:914-921, 2020.

Ngaage, L. M., Wu, Y., Ge S, Gebran, S., Liang, F., Rada, E. M., Nam, A. J., Silverman, R. P., Rasko, Y. M. Factors influencing the local cure rate of hidradenitis suppurativa following wide local excision. Int Wound J, 17:117-123, 2020.

Shavit, E., Pawliwec, A., Alavi, A., George, R. The surgeon’s perspective: a retrospective study of wide local excisions taken to healthy subcutaneous fat in the management of advanced hidradenitis suppurativa. Can J Surg. 2020;63(2):E94-E99. Published 2020 Feb 28. doi:10.1503/cjs.003119

Deckers, I. E., Dahi, Y., van der Zee H. H., Prens, E. P. Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures. J Eur Acad Dermatol Venereol, 32(3):459-462. 2018.

Walter, A. C., Meissner, M., Kaufmann, R., Valesky, E., Pinter, A., Hidradenitis suppurativa after radical surgery - longterm follow-up for recurrences and associated factors. Dermatol Surg, 44:1323–1331, 2018.

Humphries, L. S., Kueberuwa, E., Beederman, M., Gottlieb, L. J. Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: A single-center experience. J Plast Reconstr Aesthet Surg, 69(4):554-566, 2016.

Paskaleva, R., Hristakieva, E., Lavcheva, R. Rehabilitation program for surgery of hidradenitis suppurativa. Fundamental and applied studies in EU and CIS Countries, VII. International Academic Congress, papers and commentaries, Cambridge University Press 8:120-127, 2017.

Hazen Paul G. Recurrences of hidradenitis suppurativa after radical surgery, Practice Update, Dermatology, 2018

Schneider-Burrus, S., Kalus, S., Fritz, B., Wolk, K., Gomis-Kleindienst, S., Sabat, R. The impact of hidradenitis suppurativa on professional life. Br J Dermatol,188(1):122-130, 2023.

Downloads

Published

2024-09-24

Issue

Section

Original Contributions

How to Cite

HIGH REMISSION AND LOW RECURRENCE RATES OF HIDRADENITIS SUPPURATIVA LESIONS TREATED BY REGIONAL COMPLETE EXCISION AND SECONDARY INTENTION WOUND HEALING AFTER 36 MONTHS OF FOLLOW-UP. (2024). TRAKIA JOURNAL OF SCIENCES, 22(3), 6. https://doi.org/10.15547/tjs.2024.03.007

Similar Articles

11-20 of 22

You may also start an advanced similarity search for this article.